Community post
Discussing ASCO & EHA 2025 Myeloma Highlights
AI-generated title
🎧 New Podcast Alert!
In this plain-language episode, we break down the most important highlights from ASCO 2025 and EHA 2025, making complex myeloma updates easier to understand.
🩸 Joined by an expert patient and a myeloma specialist, we cover:
MRD-driven strategies
Novel immunotherapies
Supportive care
Precision medicine & AI
MRD negativity is becoming a key therapeutic goal, and supportive, personalized care continues to improve outcomes and quality of life for people living with multiple myeloma.
🎙️ Listen now and stay informed!
👉https://open.spotify.com/episode/5u4tj34rjNMzVUdfn6Cln3
No comments yet.